Medtronic (MDT) is likely to have prioritized its R&D investments, which might get reflected in the fiscal Q4 results.
Both stocks have outpaced the S&P 500 so far this year. Vertex is a long-time leader in the treatment of cystic fibrosis.
Within cardiac rhythm management, Medtronic's (MDT) pacing business continues to outperform the market, banking on strong global growth of its Micra leadless pacemaker family.
Medtronic has faced hurdles of its own making over the last three years. The company's pipeline, however, has recently delivered some wins.
The first half of May brought dividend boosts from several popular companies, including Apple and Cardinal Health. The big increases came from Chesapeake Utilities, Pool Corporation, and Tetra Tech.
Stryker and Medtronic are two of the biggest names in the medical device industry. Stryker is growing steadily, and its recent headwinds are clearing up.
Medtronic is trying to increase its efficiency with an internal overhaul. At the same time, it's planning on buying a bunch of smaller companies.
DUBLIN , May 11, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal y
This healthcare company has a promising future as both a growth and income stock. This cannabis company has the potential to thrive in a fiercely competitive market.

Medtronic's Fortunes May Be Changing

07:07am, Thursday, 11'th May 2023
Medtronic is one of the largest medical device companies in the world and it is a market leader. The stock is yielding 3%+, almost at a decade high with a dividend growth rate of about 8% annually.
Stocks have been taking a beating over the past year and a half, and there are some potential bargains out there right now. According to some of the smartest investors in the world, a bear market is n

Is Medtronic Stock a Buy Now?

05:30am, Sunday, 07'th May 2023
Medtronic has delivered a track record of earnings growth -- and recently beat earnings expectations even in a difficult economy. Still, the company may continue to face some headwinds in the coming m
Increasingly, technologies other than drugs are working to improve patient health. From diagnostic systems like MRIs and CAT scans to high-tech glucose monitoring systems to devices that destroy tumor
Medtronic has been a very reliable payer of dividends for more than four decades. Management claims the dividend remains a priority for its capital allocation.

Is Medtronic Stock a Buy Now?

05:36am, Tuesday, 02'nd May 2023
Medtronic got some excellent news for its diabetes business. Inflation and currency exchange rates are hurting cash flow.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE